Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Christopher P. Cannon
Based on 18 articles published since 2010
(Why 18 articles?)
||||
Expertise Level
The expertise of Christopher P. Cannon ranks in the
  • Top 0.082%
  • ... of 31,653 published authors worldwide on Hypercholesterolemia
  • ... from 2010 through 2020
  • ... based on contributions to 18 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Harvard University Boston   Contact    
2019
  • Departments of Medicine (Cardiovascular Division) and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: https://twitter.com/AvinainderSingh. · Departments of Medicine (Cardiovascular Division) and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Center for Observational Research, Amgen Inc., Thousand Oaks, California. · Global Development, Amgen Inc., Thousand Oaks, California. · Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. · Cardiovascular Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut. · Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: https://twitter.com/DLBhattMD. · Departments of Medicine (Cardiovascular Division) and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 31097165
2018
  • Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: · Department of Medicine and Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, Canada. · Oregon Health & Science University, Knight Cardiovascular Institute, Center for Preventive Cardiology, Portland, Oregon. · Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 30012326
  • Department of Integrated Medical Sciences, Florida Atlantic University, Charles E. Schmidt College of Medicine, Florida. · Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts. · Pubmed 29512936
  • 1 Imperial Centre for Cardiovascular Disease Prevention Department of Primary Care and Public Health Imperial College London United Kingdom. · 2 Columbia University New York NY. · 3 Department of Medicine University of Chicago Medicine Chicago IL. · 4 University of Colorado Anschutz Medical Campus Aurora CO. · 5 Cardiovascular Medicine Innovation Brigham and Women's Hospital Boston MA. · 6 Sanofi Bridgewater NJ. · 7 Sanofi Paris France. · 8 Regeneron Pharmaceuticals, Inc. Tarrytown NY. · 9 Sanofi Chilly-Mazarin France. · Pubmed 30371190
  • CGH Medical Center, Sterling, Illinois, USA; and Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: · Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Harvard Clinical Research Institute, Boston, Massachusetts, USA. · University of Edinburgh, Edinburgh, UK. · Perelman School of Medicine, Smilow Centre for Translational Research, Philadelphia, Pennsylvania, USA. · Section of Nephrology, Boston University School of Medicine, Boston, Massachusetts, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA. · Sanofi, Bridgewater, New Jersey, USA. · Sanofi, Chilly-Mazarin, France. · Sanofi, Chilly-Mazarin, France; IviData Stats, Levallois-Perret, Paris, France. · Department of Hypertension, Medical University of Lodz, Lodz, Poland. · Pubmed 29526502
  • Division of Translational Research and Clinical Epidemiology, Division of Cardiovascular Medicine, Wayne State University School of Medicine, Detroit, MI, USA. · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA. · Department of Cardiology, Charite Universitäts Medizin Berlin, Campus Benjamin Franklin, Berlin, Germany. · Department of Cardiology, University Heart Center, University Hospital Zurich, Switzerland. · Department of Pharmacological and Biomolecular Sciences, MultiMedica Istituto di Ricovero e Cura a Carattere Scientifico, University of Milan, Via Balzaretti, 9, 20133 Milan, Italy. · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Pubmed 29020411
2017
  • Cardiovascular Center of Sarasota, Sarasota, Florida. Electronic address: · Harvard Clinical Research Institute, Boston, Massachusetts. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, Virginia. · L'Institut du Thorax, CHU de Nantes, Nantes, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · University of Edinburgh, Edinburgh, UK. · Pubmed 28750828
  • Baim Institute for Clinical Research, Boston, Massachusetts. · Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts. · Global Health Economics and Outcomes Research, Sanofi, Bridgewater, New Jersey. · Axtria, Berkeley Heights, New Jersey. · Department of Cardiovascular Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts. · Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, New York. · Program Direction, Cardiovascular and Metabolism, Regeneron Pharmaceuticals, Inc, Tarrytown, New York. · Pubmed 28768335
2016
  • Sanofi, Paris, France. · Sanofi, Paris, France · Sanofi, Frankfurt, Germany. · Sanofi, Montpellier, France. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY. · Harvard Clinical Research Institute, Boston, MA. · Sanofi, Bridgewater, NJ. · Pubmed 27287699
2015
  • Harvard Clinical Research Institute, Boston, MA, USA Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA · Harvard Clinical Research Institute, Boston, MA, USA Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 25971287
  • The Christ Hospital, Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH. Electronic address: · University of Iowa, Iowa City, IA. · Harvard Clinical Research Institute, Boston, MA. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY. · Sanofi, Bridgewater, NJ. · University of Dundee, Dundee, Scotland, United Kingdom. · Pubmed 26027630
  • Division of Clinical Pharmacology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: · Hartford Hospital, Hartford, CT, USA. · Harvard Clinical Research Institute, Boston, MA, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, MA, USA. · Duke University Medical Center, Durham, NC, USA. · Lipid Clinic, Centre Hospitalier Universitaire de Québec, Laval University, Québec, Canada. · McGuire VA Medical Center, Richmond, VA, USA. · Groupe Hospitalier Pitié-Salpêtrière (Assistance Publique-Hôpitaux de Paris), Paris, France. · Department of Medicine, Emory University, Atlanta, GA, USA. · Mayo Clinic, Department of Cardiovascular Diseases, Rochester, MN, USA. · PCSK9 Development and Launch Unit, Sanofi, Montpellier, France. · Department of Biostatistics, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Clinical Sciences, Cardiovascular & Metabolism Therapeutics, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Pubmed 26687696
  • Harvard Clinical Research Institute, 930 W. Commonwealth Ave, Boston, MA 02215, USA · Department of Endocrinology, L'Institut du Thorax, CHU de Nantes, Nantes, France. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, VA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · University of Dundee, Dundee, UK. · Pubmed 25687353
2014
  • Office of the Vice President, Weill Cornell Medical College, New York, NY, USA · Merck Research Laboratories, Rahway, NJ, USA. · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA. · Utah Foundation for Biomedical Research and Utah Lipid Center, Salt Lake City, UT, USA. · Office of the Vice President, Weill Cornell Medical College, New York, NY, USA. · Centre for Vascular Research, University of New South Wales, Sydney, Australia, USA. · Pubmed 24737712
Probable:    Miscellaneous institutions in Boston      
2017
  • Baim Institute for Clinical Research, Boston, Massachusetts. · Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts. · Global Health Economics and Outcomes Research, Sanofi, Bridgewater, New Jersey. · Axtria, Berkeley Heights, New Jersey. · Department of Cardiovascular Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts. · Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, New York. · Program Direction, Cardiovascular and Metabolism, Regeneron Pharmaceuticals, Inc, Tarrytown, New York. · Pubmed 28768335
Possible:    Miscellaneous institutions in Buffalo      
2010
  • Department of Medicine, SUNY at Buffalo School of Medicine, Buffalo, NY, USA. · Pubmed 20802270
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 18 total) written by Christopher P. Cannon about Hypercholesterolemia:

  • Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction. 2019
  • The Evolving Future of PCSK9 Inhibitors. 2018
  • PCSK9 inhibitor valuation: A science-based review of the two recent models. 2018
  • Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials. 2018
  • Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease. 2018
  • Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. 2018
  • Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II). 2017
  • Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease. 2017
  • Relationship Between Low-Density Lipoprotein Cholesterol, Free Proprotein Convertase Subtilisin/Kexin Type 9, and Alirocumab Levels After Different Lipid-Lowering Strategies. 2016
  • Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful? 2016
Show List of Full Article Records
Google Searches

Learn more about Christopher P. Cannon using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University Boston
Miscellaneous institutions in Boston
Miscellaneous institutions in Buffalo
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University Boston
2019
  • Departments of Medicine (Cardiovascular Division) and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: https://twitter.com/AvinainderSingh. · Departments of Medicine (Cardiovascular Division) and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Center for Observational Research, Amgen Inc., Thousand Oaks, California. · Global Development, Amgen Inc., Thousand Oaks, California. · Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. · Cardiovascular Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut. · Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: https://twitter.com/DLBhattMD. · Departments of Medicine (Cardiovascular Division) and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 31097165
2018
  • Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: · Department of Medicine and Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, Canada. · Oregon Health & Science University, Knight Cardiovascular Institute, Center for Preventive Cardiology, Portland, Oregon. · Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 30012326
  • Department of Integrated Medical Sciences, Florida Atlantic University, Charles E. Schmidt College of Medicine, Florida. · Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts. · Pubmed 29512936
  • 1 Imperial Centre for Cardiovascular Disease Prevention Department of Primary Care and Public Health Imperial College London United Kingdom. · 2 Columbia University New York NY. · 3 Department of Medicine University of Chicago Medicine Chicago IL. · 4 University of Colorado Anschutz Medical Campus Aurora CO. · 5 Cardiovascular Medicine Innovation Brigham and Women's Hospital Boston MA. · 6 Sanofi Bridgewater NJ. · 7 Sanofi Paris France. · 8 Regeneron Pharmaceuticals, Inc. Tarrytown NY. · 9 Sanofi Chilly-Mazarin France. · Pubmed 30371190
  • CGH Medical Center, Sterling, Illinois, USA; and Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: · Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Harvard Clinical Research Institute, Boston, Massachusetts, USA. · University of Edinburgh, Edinburgh, UK. · Perelman School of Medicine, Smilow Centre for Translational Research, Philadelphia, Pennsylvania, USA. · Section of Nephrology, Boston University School of Medicine, Boston, Massachusetts, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA. · Sanofi, Bridgewater, New Jersey, USA. · Sanofi, Chilly-Mazarin, France. · Sanofi, Chilly-Mazarin, France; IviData Stats, Levallois-Perret, Paris, France. · Department of Hypertension, Medical University of Lodz, Lodz, Poland. · Pubmed 29526502
  • Division of Translational Research and Clinical Epidemiology, Division of Cardiovascular Medicine, Wayne State University School of Medicine, Detroit, MI, USA. · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA. · Department of Cardiology, Charite Universitäts Medizin Berlin, Campus Benjamin Franklin, Berlin, Germany. · Department of Cardiology, University Heart Center, University Hospital Zurich, Switzerland. · Department of Pharmacological and Biomolecular Sciences, MultiMedica Istituto di Ricovero e Cura a Carattere Scientifico, University of Milan, Via Balzaretti, 9, 20133 Milan, Italy. · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Pubmed 29020411
2017
  • Cardiovascular Center of Sarasota, Sarasota, Florida. Electronic address: · Harvard Clinical Research Institute, Boston, Massachusetts. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, Virginia. · L'Institut du Thorax, CHU de Nantes, Nantes, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · University of Edinburgh, Edinburgh, UK. · Pubmed 28750828
  • Baim Institute for Clinical Research, Boston, Massachusetts. · Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts. · Global Health Economics and Outcomes Research, Sanofi, Bridgewater, New Jersey. · Axtria, Berkeley Heights, New Jersey. · Department of Cardiovascular Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts. · Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, New York. · Program Direction, Cardiovascular and Metabolism, Regeneron Pharmaceuticals, Inc, Tarrytown, New York. · Pubmed 28768335
2016
  • Sanofi, Paris, France. · Sanofi, Paris, France · Sanofi, Frankfurt, Germany. · Sanofi, Montpellier, France. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY. · Harvard Clinical Research Institute, Boston, MA. · Sanofi, Bridgewater, NJ. · Pubmed 27287699
2015
  • Harvard Clinical Research Institute, Boston, MA, USA Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA · Harvard Clinical Research Institute, Boston, MA, USA Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 25971287
  • The Christ Hospital, Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH. Electronic address: · University of Iowa, Iowa City, IA. · Harvard Clinical Research Institute, Boston, MA. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY. · Sanofi, Bridgewater, NJ. · University of Dundee, Dundee, Scotland, United Kingdom. · Pubmed 26027630
  • Division of Clinical Pharmacology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: · Hartford Hospital, Hartford, CT, USA. · Harvard Clinical Research Institute, Boston, MA, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, MA, USA. · Duke University Medical Center, Durham, NC, USA. · Lipid Clinic, Centre Hospitalier Universitaire de Québec, Laval University, Québec, Canada. · McGuire VA Medical Center, Richmond, VA, USA. · Groupe Hospitalier Pitié-Salpêtrière (Assistance Publique-Hôpitaux de Paris), Paris, France. · Department of Medicine, Emory University, Atlanta, GA, USA. · Mayo Clinic, Department of Cardiovascular Diseases, Rochester, MN, USA. · PCSK9 Development and Launch Unit, Sanofi, Montpellier, France. · Department of Biostatistics, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Clinical Sciences, Cardiovascular & Metabolism Therapeutics, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Pubmed 26687696
  • Harvard Clinical Research Institute, 930 W. Commonwealth Ave, Boston, MA 02215, USA · Department of Endocrinology, L'Institut du Thorax, CHU de Nantes, Nantes, France. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, VA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · University of Dundee, Dundee, UK. · Pubmed 25687353
2014
  • Office of the Vice President, Weill Cornell Medical College, New York, NY, USA · Merck Research Laboratories, Rahway, NJ, USA. · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA. · Utah Foundation for Biomedical Research and Utah Lipid Center, Salt Lake City, UT, USA. · Office of the Vice President, Weill Cornell Medical College, New York, NY, USA. · Centre for Vascular Research, University of New South Wales, Sydney, Australia, USA. · Pubmed 24737712
Miscellaneous institutions in Boston
2017
  • Baim Institute for Clinical Research, Boston, Massachusetts. · Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts. · Global Health Economics and Outcomes Research, Sanofi, Bridgewater, New Jersey. · Axtria, Berkeley Heights, New Jersey. · Department of Cardiovascular Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts. · Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, New York. · Program Direction, Cardiovascular and Metabolism, Regeneron Pharmaceuticals, Inc, Tarrytown, New York. · Pubmed 28768335
Miscellaneous institutions in Buffalo
2010
  • Department of Medicine, SUNY at Buffalo School of Medicine, Buffalo, NY, USA. · Pubmed 20802270
Yearly article counts 01522410201
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.